Φορτώνει......
The challenge of finding new therapeutic avenues in soft tissue sarcomas
Soft tissue sarcomas are rare malignancies of mesenchymal origin comprising about 1% of all adult cancers. Systemic therapies for locally advanced and metastatic disease have been restricted for decades to very few effective and approved agents such as doxorubicin and ifosfamide. However, new therap...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Clin Sarcoma Res |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457009/ https://ncbi.nlm.nih.gov/pubmed/31007895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13569-019-0115-4 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|